Stock 2511 HIGHTIDE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages HighTide Therapeutics, Inc.

Equities

2511

KYG4568L1023

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:42 28/06/2024 BST 		5-day change 1st Jan Change
1.41 HKD -1.40% Intraday chart for HighTide Therapeutics, Inc. -61.68% -89.12%
06-21 217,225,044 Shares of HighTide Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2024. CI
06-18 8,774,232 Shares of HighTide Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 18-JUN-2024. CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HighTide Therapeutics Completes Patient Enrolment for Phase II Trial of Metabolic Modulator
Hightide Therapeutics, Inc. Announces Completion of Patient Enrollment in Phase IIb Clinical Trial Evaluating HTD1801
HighTide Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
HighTide Therapeutics, Inc. Announces Resignation of Mr. LI LI as A Non-Executive Director
HighTide Therapeutics to Set Up New Plant in China Expansion Plans
China's Curbs on Game Spending Pulls Down Hong Kong Stocks; One Out of Four Trading Debutants Drop at Close
HighTide Therapeutics, Inc. has completed an IPO in the amount of HKD 278.231 million.
HighTide Therapeutics, Inc. has filed an IPO in the amount of HKD 278.231 million.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2511 Stock
  4. News HighTide Therapeutics, Inc.
  5. Other languages